United Kingdom· GB-APID-42464211000001108
Inaqovi 35mg/100mg tablets
A medicinal product containing decitabine + cedazuridine, registered in United Kingdom by Otsuka Pharmaceuticals (U.K.) Ltd.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Decitabine + Cedazuridine
- Manufacturer
- Otsuka Pharmaceuticals (U.K.) Ltd
- Country
- United Kingdom (GB)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 1
- gtin5038256002948
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Decitabine + cedazuridine in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CanadaINQOVITAIHO PHARMA CANADA, INC.
- CzechiaINAQOVIOtsuka Pharmaceutical Netherlands B.V., Amsterdam
- SpainINAQOVI 35 MG/100 MG COMPRIMIDOS RECUBIERTOS CON PELICULAOtsuka Pharmaceutical Netherlands B.V.
- FinlandInaqoviOtsuka Pharmaceutical Netherlands B.V.
- IrelandInaqovi 35 mg/100 mg film-coated tabletsOtsuka Pharmaceutical Netherlands B.V.
- IcelandInaqoviOtsuka Pharmaceutical Netherlands B.V.*
- NetherlandsInaqovi 35 mg/100, fimomhulde tablettenOtsuka Pharmaceutical Netherlands B.V.
- NorwayInaqoviOtsuka Pharmaceutical Netherlands B.V.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Inaqovi
- Liechtenstein · Inaqovi
- Norway · Inaqovi
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/4d332da3-f1a1-4770-821e-199682391056 GET /v1/drugs/4d332da3-f1a1-4770-821e-199682391056?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "42464211000001108",
"desc": "Inaqovi 35mg/100mg tablets (Otsuka Pharmaceuticals (U.K.) Ltd)",
"form": "Oral tablet",
"vpid": "42476911000001102",
"source": "dmd",
"vtm_id": "890336004",
"strength": "100 mg",
"substance": "Decitabine + Cedazuridine",
"ingredient": "Cedazuridine",
"supplier_code": "3593311000001101"
}See everything about decitabine + cedazuridine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.